(Q44193677)

30 November 2017

Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand (English)

1 reference

30 November 2017

0 references

1 reference

Somsak Lolekha

1

1 reference

30 November 2017

Boonyarat Warachit

2

1 reference

30 November 2017

Amporn Hirunyachote

3

1 reference

30 November 2017

Piyaporn Bowonkiratikachorn

4

1 reference

30 November 2017

David J West

5

1 reference

30 November 2017

Gabriele Poerschke

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

20

1 reference

30 November 2017

31-32

1 reference

30 November 2017

3739-3743

1 reference

Global programme for control of hepatitis B infection

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900358-4

7 January 2021

10.1016/S0264-410X(02)00358-4

Identifiers

DOI

1 reference

30 November 2017

1 reference